Free Trial

West Pharmaceutical Services (WST) Competitors

West Pharmaceutical Services logo
$211.27 +1.01 (+0.48%)
Closing price 03:59 PM Eastern
Extended Trading
$211.24 -0.03 (-0.01%)
As of 04:29 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

WST vs. COO, ALGN, MMSI, ICUI, HAE, XRAY, QDEL, NEOG, STAA, and CERS

Should you be buying West Pharmaceutical Services stock or one of its competitors? The main competitors of West Pharmaceutical Services include Cooper Companies (COO), Align Technology (ALGN), Merit Medical Systems (MMSI), ICU Medical (ICUI), Haemonetics (HAE), DENTSPLY SIRONA (XRAY), QuidelOrtho (QDEL), Neogen (NEOG), STAAR Surgical (STAA), and Cerus (CERS). These companies are all part of the "health care supplies" industry.

West Pharmaceutical Services vs.

West Pharmaceutical Services (NYSE:WST) and Cooper Companies (NASDAQ:COO) are both large-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, earnings, valuation, media sentiment, analyst recommendations, institutional ownership, community ranking, profitability and dividends.

West Pharmaceutical Services has a beta of 1.22, meaning that its share price is 22% more volatile than the S&P 500. Comparatively, Cooper Companies has a beta of 1.01, meaning that its share price is 1% more volatile than the S&P 500.

West Pharmaceutical Services currently has a consensus target price of $332.50, indicating a potential upside of 57.38%. Cooper Companies has a consensus target price of $110.25, indicating a potential upside of 33.96%. Given West Pharmaceutical Services' stronger consensus rating and higher possible upside, analysts plainly believe West Pharmaceutical Services is more favorable than Cooper Companies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
West Pharmaceutical Services
0 Sell rating(s)
1 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
3.00
Cooper Companies
0 Sell rating(s)
3 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.70

93.9% of West Pharmaceutical Services shares are owned by institutional investors. Comparatively, 24.4% of Cooper Companies shares are owned by institutional investors. 0.6% of West Pharmaceutical Services shares are owned by company insiders. Comparatively, 2.0% of Cooper Companies shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

In the previous week, West Pharmaceutical Services had 1 more articles in the media than Cooper Companies. MarketBeat recorded 25 mentions for West Pharmaceutical Services and 24 mentions for Cooper Companies. Cooper Companies' average media sentiment score of 1.12 beat West Pharmaceutical Services' score of 0.74 indicating that Cooper Companies is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
West Pharmaceutical Services
15 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
2 Negative mention(s)
1 Very Negative mention(s)
Positive
Cooper Companies
18 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
2 Negative mention(s)
1 Very Negative mention(s)
Positive

West Pharmaceutical Services has a net margin of 17.03% compared to Cooper Companies' net margin of 10.07%. West Pharmaceutical Services' return on equity of 18.60% beat Cooper Companies' return on equity.

Company Net Margins Return on Equity Return on Assets
West Pharmaceutical Services17.03% 18.60% 13.80%
Cooper Companies 10.07%9.38%6.09%

West Pharmaceutical Services has higher earnings, but lower revenue than Cooper Companies. West Pharmaceutical Services is trading at a lower price-to-earnings ratio than Cooper Companies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
West Pharmaceutical Services$2.90B5.24$492.70M$6.3733.17
Cooper Companies$3.93B4.19$392.30M$2.0639.95

Cooper Companies received 354 more outperform votes than West Pharmaceutical Services when rated by MarketBeat users. Likewise, 66.42% of users gave Cooper Companies an outperform vote while only 56.11% of users gave West Pharmaceutical Services an outperform vote.

CompanyUnderperformOutperform
West Pharmaceutical ServicesOutperform Votes
271
56.11%
Underperform Votes
212
43.89%
Cooper CompaniesOutperform Votes
625
66.42%
Underperform Votes
316
33.58%

Summary

West Pharmaceutical Services beats Cooper Companies on 12 of the 19 factors compared between the two stocks.

Get West Pharmaceutical Services News Delivered to You Automatically

Sign up to receive the latest news and ratings for WST and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

WST vs. The Competition

MetricWest Pharmaceutical ServicesSurgical & medical instruments IndustryMedical SectorNYSE Exchange
Market Cap$15.18B$4.39B$5.55B$19.22B
Dividend Yield0.39%39.93%5.09%4.00%
P/E Ratio31.5829.8622.6833.45
Price / Sales5.2457.90404.2829.18
Price / Cash22.6051.0838.1817.52
Price / Book5.696.226.794.55
Net Income$492.70M$68.15M$3.22B$1.02B
7 Day Performance-1.53%1.00%2.44%2.18%
1 Month Performance-4.61%-1.80%3.78%-2.05%
1 Year Performance-42.70%21.29%17.05%5.45%

West Pharmaceutical Services Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
WST
West Pharmaceutical Services
4.6619 of 5 stars
$211.27
+0.5%
$332.50
+57.4%
-42.1%$15.18B$2.90B31.5810,700
COO
Cooper Companies
3.2237 of 5 stars
$81.85
+1.2%
$110.25
+34.7%
-9.5%$16.37B$3.93B41.9714,000Positive News
ALGN
Align Technology
4.4007 of 5 stars
$181.09
-1.2%
$246.17
+35.9%
-37.9%$13.26B$4.00B32.2823,200Earnings Report
Analyst Forecast
News Coverage
MMSI
Merit Medical Systems
3.9899 of 5 stars
$95.44
+0.9%
$109.00
+14.2%
+21.6%$5.64B$1.36B46.786,850Short Interest ↑
ICUI
ICU Medical
3.881 of 5 stars
$135.90
+0.2%
$162.67
+19.7%
+39.4%$3.34B$2.38B-29.7414,500Upcoming Earnings
Analyst Upgrade
HAE
Haemonetics
4.6413 of 5 stars
$62.55
+0.1%
$101.22
+61.8%
-31.6%$3.14B$1.37B24.632,820Upcoming Earnings
News Coverage
Positive News
XRAY
DENTSPLY SIRONA
4.9039 of 5 stars
$13.87
+0.9%
$22.58
+62.8%
-53.8%$2.76B$3.79B-6.7015,000Upcoming Earnings
Analyst Forecast
Gap Up
QDEL
QuidelOrtho
4.5515 of 5 stars
$28.96
+3.1%
$46.83
+61.7%
-29.7%$1.95B$2.78B-0.967,000Upcoming Earnings
Analyst Revision
News Coverage
Positive News
Gap Up
NEOG
Neogen
3.81 of 5 stars
$5.14
-0.4%
$9.00
+75.1%
-58.0%$1.12B$906.00M-2.352,110Analyst Revision
Positive News
STAA
STAAR Surgical
4.3387 of 5 stars
$18.16
+0.7%
$24.25
+33.5%
-59.0%$895.74M$313.90M-44.29960Upcoming Earnings
CERS
Cerus
2.0804 of 5 stars
$1.34
-0.7%
$3.50
+161.2%
-24.4%$256.15M$180.27M-12.18290Earnings Report
News Coverage

Related Companies and Tools


This page (NYSE:WST) was last updated on 5/2/2025 by MarketBeat.com Staff
From Our Partners